{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:47:03Z","timestamp":1786718823072,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Ann"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ua.ua_65_17","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:14:31Z","timestamp":1519344871000},"page":"154","source":"Crossref","is-referenced-by-count":12,"title":["Prospective study to evaluate the clinical outcome of intralesional interferon-\u03b12b in the management of Peyronie's disease"],"prefix":"10.4103","volume":"10","author":[{"given":"AshokKumar","family":"Sokhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NileshKumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Jhanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawaljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DurgeshKumar","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-7796.226084-1","first-page":"62","volume-title":"Francois Gigot de la Peyronie (1678-1747)","author":"Carson","year":"1981","journal-title":"Invest Urol"},{"key":"key-10.4103\/0974-7796.226084-2","first-page":"653","volume-title":"Psychological impact of Peyronie's disease: A review","author":"Nelson","year":"2013","journal-title":"J Sex Med"},{"key":"key-10.4103\/0974-7796.226084-3","first-page":"1985","volume-title":"The chronology of depression and distress in men with Peyronie's disease","author":"Nelson","year":"2008","journal-title":"J Sex Med"},{"key":"key-10.4103\/0974-7796.226084-4","first-page":"168","volume-title":"Psychosexual symptoms and treatment of peyronie's disease within a collaborative care model","author":"Hartzell","year":"2014","journal-title":"Sex Med"},{"key":"key-10.4103\/0974-7796.226084-5","first-page":"282503","volume-title":"A population-based study of Peyronie's disease: Prevalence and treatment patterns in the United States","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol"},{"key":"key-10.4103\/0974-7796.226084-6","first-page":"1376","volume-title":"The natural history of Peyronie's disease","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.226084-7","first-page":"291","volume-title":"Mechanisms of disease: New insights into the cellular and molecular pathology of Peyronie's disease","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"key-10.4103\/0974-7796.226084-8","first-page":"1729","volume-title":"Testosterone deficiency and Peyronie's disease: Pilot data suggesting a significant relationship","author":"Moreno","year":"2009","journal-title":"J Sex Med"},{"key":"key-10.4103\/0974-7796.226084-9","first-page":"1038","volume-title":"Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: A randomized and prospective study","author":"Inal","year":"2006","journal-title":"Urology"},{"key":"key-10.4103\/0974-7796.226084-10","first-page":"6","volume-title":"Peyronie's disease: What's around the bend?","author":"Bilgutay","year":"2016","journal-title":"Indian J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0970-1591","issn-type":"print"},{"key":"key-10.4103\/0974-7796.226084-11","first-page":"2268","volume-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.226084-12","first-page":"650","volume-title":"Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: Results from two large, double-blind, randomized, placebo-controlled, phase III studies","author":"Lipshultz","year":"2015","journal-title":"BJU Int"},{"key":"key-10.4103\/0974-7796.226084-13","first-page":"543","volume-title":"EAU guidelines on penile curvature","author":"Hatzimouratidis","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/0974-7796.226084-14","first-page":"285","volume-title":", Somers KD, Jordan SG, Schlossberg SM.Proposal: Trauma as the cause of the Peyronie's lesion","author":"Devine","year":"1997","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.226084-15","first-page":"570","volume-title":"Risk factors for Peyronie's disease: A case-control study","author":"Bjekic","year":"2006","journal-title":"BJU Int"},{"key":"key-10.4103\/0974-7796.226084-16","first-page":"23","volume-title":"Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline","author":"Alizadeh","year":"2014","journal-title":"Glob J Health Sci"},{"key":"key-10.4103\/0974-7796.226084-17","first-page":"621","volume-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","author":"Levine","year":"2002","journal-title":"J Urol"},{"key":"key-10.4103\/0974-7796.226084-18","first-page":"869","volume-title":"The clinical application of the interferons: A review","author":"Stuart-Harris","year":"1992","journal-title":"Med J Aust"},{"key":"key-10.4103\/0974-7796.226084-19","first-page":"89","volume-title":"Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta, and - gamma","author":"Duncan","year":"1991","journal-title":"Scand J Urol Nephrol"},{"key":"key-10.4103\/0974-7796.226084-20","first-page":"207","volume-title":"Stimulation of collagen production in an in vitro model for Peyronie's disease","author":"Ahuja","year":"1999","journal-title":"Int J Impot Res"},{"key":"key-10.4103\/0974-7796.226084-21","first-page":"394","volume-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon \u03b1-2B for minimally invasive treatment for Peyronie's disease","author":"Hellstrom","year":"2006","journal-title":"The J Urol"},{"key":"key-10.4103\/0974-7796.226084-22","first-page":"950","volume-title":"Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease","author":"Cavallini","year":"2007","journal-title":"Urology"},{"key":"key-10.4103\/0974-7796.226084-23","first-page":"467","volume-title":"Effect of intralesional verapamil for treatment of Peyronie's disease: A randomized single blind, placebo controlled study","author":"Shirazi","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/0974-7796.226084-24","first-page":"694","volume-title":"Short-term keloid treatment in vivo with human interferon alpha 2b results in a selective and persistent normalization of keloid fibroblast collagen glycosaminoglycan, and collagenase production in vitro","author":"Berman","year":"1989","journal-title":"J Am Acad Dermatol"}],"container-title":["Urology Annals"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:40:13Z","timestamp":1786714813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/UA.UA_65_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"alternative-id":["226084"],"URL":"https:\/\/doi.org\/10.4103\/ua.ua_65_17","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733162287.793574535","asserted-by":"object"}]},"ISSN":["0974-7796"],"issn-type":[{"value":"0974-7796","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}